Pegzilarginase Uses, Dosage, Side Effects and more
Pegzilarginase is under investigation in clinical trial NCT02488044 (A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency).
| Attribute | Details |
|---|---|
| Trade Name | Pegzilarginase |
| Generic | Pegzilarginase |
| Pegzilarginase Other Names | Pegzilarginase |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
